CANADIAN DAILY STOCK REPORT
Immunovaccine Inc. (TSX:IMV), Canada's 11th largest Biotechnology company by market cap, has dropped 5.0c (3.8%) from its last trading session of March 01 to close at CAD1.25. Compared with the S&P/TSX 60 Index which fell 1.3 points (0.1%) in the day, the relative price change was -3.7%. The fall was exacerbated by robust volume of 1.5 times the average daily volume of 121,149 shares.
Pierre Labbe insider bought 15,000 shares worth
RelSci News & Alerts gets you: